Abstract
Background
The head and neck is the most common site of mucosal melanoma, a cancer with poor prognosis. In contrast to cutaneous melanoma, mucosal melanoma of the head and neck (MMHN) is uncommon, with limited data regarding outcomes and prognostic factors drawn from small, single-institution case series. In order to identify factors predictive of survival, we analyzed MMHN outcomes in a large US cohort.
Methods
MMHN cases (n = 815) diagnosed in the USA between 1973 and 2007 were analyzed in the Surveillance, Epidemiology, and End Results registry, and cause of death was individually determined in 778 (95.5%) cases. Kaplan–Meier survival analysis and Cox proportional hazards regression were used to analyze prognostic variables.
Results
Disease-specific survival status was determined in 778 (95.5%) cases. The 5- and 10-year rates of overall survival (OS) were 25.2 and 12.2%; disease-specific survival (DSS), 32.4 and 19.3%. On multivariable analysis, anatomic primary site was an independent predictor of OS and DSS, with tumors in the nasal cavity and oral cavity associated with survival superior to tumors in the nasopharynx and paranasal sinuses. Age > 70 years, tumor size, nodal status, and distant metastasis status were additional independent predictors of poorer survival.
Conclusions
In this large cohort of patients with MMHN, we have identified several novel factors robustly predictive of overall and melanoma-specific survival.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer. 1997; 80: 1373–1386.
Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma––a summary of 84,836 cases from the past decade. Cancer. 1998; 83: 1664–1678.
Andersen LJ, Berthelsen A, Hansen HS. Malignant melanoma of the upper respiratory tract and the oral cavity. J Otolaryngol. 1992; 21: 180–185.
Temam S, Mamelle G, Marandas P, Wibault P, Avril MF, Janot F, et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer. 2005; 103: 313–319.
Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck. 2002; 24: 247–257.
Loree TR, Mullins AP, Spellman J, North JH, Hicks WL. Head and neck mucosal melanoma: a 32-year review. Ear Nose Throat J. 1999; 78: 372–375.
Lee SP, Shimizu KT, Tran LM, Juillard G, Calcaterra TC. Mucosal melanoma of the head and neck––the impact of local control on survival. Laryngoscope. 1994; 104: 121–126.
NCI. SEER Cancer Statistics Review––SEER Cancer Statistics. 2010. Available at: http://seer.cancer.gov/csr/1975_2007/about.html. Accessed on: 15 Dec 2010.
Bachar G, Loh KS, O’Sullivan B, Goldstein D, Wood S, Brown D, et al. Mucosal melanomas of the head and neck: The Princess Margaret Hospital experience. Head Neck J Sci Spec. 2008; 30: 1325–1331.
Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the surveillance, epidemiology, and end results (SEER) program. Arch Dermatol. 2008; 144: 515–521.
NCI. Number of persons by race and hispanic ethnicity for SEER participants. 2010. Available at http://seer.cancer.gov/registries/data.html. Accessed on: 8 Oct 2010.
WHO. International classification of diseases for oncology, 3rd ed (ICD-O-3). In: Edition 2000. Geneva: World Health Organization; 2000.
Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005; 353: 2135–2147.
Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006; 24: 4340–4346.
Medina JE, Ferlito A, Pellitteri PK, Shaha AR, Khafif A, Devaney KO, et al. Current management of mucosal melanoma of the head and neck. J Surg Oncol. 2003; 83: 116–122.
Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck J Sci Spec. 2002; 24: 247–257.
Goldman JL, Roffman JD, Zak FG, Lawson W. The presence of melanocytes in the human larynx. Laryngoscope. 1972; 82: 824–835.
Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual, 7th ed. New York: Springer; 2010.
Moreno MA, Roberts DB, Kupferman ME, Demonte F, El-Naggar AK, Williams M, et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M.D. Anderson Cancer Center. Cancer. 2010; 116: 2215–2223.
Wagner M, Morris CG, Werning JW, Mendenhall WM. Mucosal melanoma of the head and neck. Am J Clin Oncol Cancer Clin Trials. 2008; 31: 43–48.
Douglas CM, Malik T, Swindell R, Lorrigan P, Slevin NJ, Homer JJ. Mucosal melanoma of the head and neck: radiotherapy or surgery? J Otolaryngol Head Neck Surg. 2010; 39: 385–392.
Wu AJ, Gomez J, Zhung JE, Chan K, Gomez DR, Wolden SL, et al. Radiotherapy after surgical resection for head and neck mucosal melanoma. Am J Clin Oncol Cancer Clin Trials. 2010; 33: 281–285.
Krengli M, Masini L, Kaanders J, et al. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A rare cancer network study. Int J Radiat Oncol Biol Phys. 2006; 65: 751–759.
Acknowledgment
This work was supported by NIH grant T32 CA009685 (to LGTM).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jethanamest, D., Vila, P.M., Sikora, A.G. et al. Predictors of Survival in Mucosal Melanoma of the Head and Neck. Ann Surg Oncol 18, 2748–2756 (2011). https://doi.org/10.1245/s10434-011-1685-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-011-1685-4